GCNT2-mediated alterations in N-glycosylation modulate SHBG levels, insulin sensitivity, and ovarian function, directly linking metabolic disruptions to PCOS clinical manifestations. This evidence concerns the gene GCNT2 and polycystic ovary syndrome.